In September of 2012 my mother was diagnosed with a form of cancer called Multiple Myeloma. I watched as her quality of life quickly became compromised and she lost her ability to do the basic tasks we take for granted each and every day. In September 2015, at the age of 62 and after fighting for exactly 3 years, my mother lost her battle. She had so much more to teach her loved ones and wished to explore so much more of the world.
Multiple Myeloma is one of three major blood cancers in the United States and constitutes approximately 1.4% of new cancer cases each year. It is a form of cancer that causes a collection of abnormal plasma cells in the bone marrow, which then interfere with the production of normal blood cells. This causes pain in the bones and makes it difficult for anyone with multiple myeloma to fight-off infections. Although it is considered incurable, Multiple Myeloma is very much treatable.
Today, the 5-year survival rate for someone with Multiple Myeloma is only 47%. However, the Multiple Myeloma Research Foundation (MMRF) is working towards changing that statistic. Since its inception in 1998, MMRF has launched new initiatives to help accelerate the pace of treating Multiple Myeloma and is changing the paradigm of how all cancer research is conducted.
Cancer affects all too many and we are on a mission to help discover new treatments and to find a cure. MMRF is the number one private funder of Multiple Myeloma research in the United States.
JODI FRIED has pledged to donate 10% of all sales to the Connie Bloom Fried tribute page for the Multiple Myeloma Research Foundation. To learn more about MMRF please click on the below link. No donation is too small to help make a difference and to save a life.